137 related articles for article (PubMed ID: 19666843)
1. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.
Nuno DW; Harrod JS; Lamping KG
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1469-77. PubMed ID: 19666843
[TBL] [Abstract][Full Text] [Related]
2. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
[TBL] [Abstract][Full Text] [Related]
3. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
4. 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.
Nelson PM; Harrod JS; Lamping KG
Exp Diabetes Res; 2012; 2012():398406. PubMed ID: 23346101
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 2 receptor-dependent increase in nitric oxide synthase activity in the endothelium of db/db mice is mediated via a MEK pathway.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Pharmacol Res; 2012 Jul; 66(1):41-50. PubMed ID: 22465219
[TBL] [Abstract][Full Text] [Related]
6. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Pharmacol Res; 2012 Jan; 65(1):56-65. PubMed ID: 21933713
[TBL] [Abstract][Full Text] [Related]
7. The role of rho kinase in sex-dependent vascular dysfunction in type 1 diabetes.
Nuno DW; Lamping KG
Exp Diabetes Res; 2010; 2010():176361. PubMed ID: 20368772
[TBL] [Abstract][Full Text] [Related]
8. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.
Mangialardi G; Katare R; Oikawa A; Meloni M; Reni C; Emanueli C; Madeddu P
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):555-64. PubMed ID: 23307872
[TBL] [Abstract][Full Text] [Related]
9. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
[TBL] [Abstract][Full Text] [Related]
10. RhoA activation contributes to sex differences in vascular contractions.
Nuno DW; Korovkina VP; England SK; Lamping KG
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1934-40. PubMed ID: 17556652
[TBL] [Abstract][Full Text] [Related]
11. Two distinct dysfunctions in diabetic mouse mesenteric artery contraction are caused by changes in the Rho A-Rho kinase signaling pathway.
Nobe K; Hashimoto T; Honda K
Eur J Pharmacol; 2012 May; 683(1-3):217-25. PubMed ID: 22465314
[TBL] [Abstract][Full Text] [Related]
12. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
Chrissobolis S; Budzyn K; Marley PD; Sobey CG
Stroke; 2004 Sep; 35(9):2200-5. PubMed ID: 15256679
[TBL] [Abstract][Full Text] [Related]
13. Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.
El-Remessy AB; Tawfik HE; Matragoon S; Pillai B; Caldwell RB; Caldwell RW
Exp Diabetes Res; 2010; 2010():247861. PubMed ID: 21052489
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
[TBL] [Abstract][Full Text] [Related]
15. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
16. Lipoxin A4 mediates aortic contraction via RHOA/RHO kinase, endothelial dysfunction and reactive oxygen species.
Wenceslau CF; McCarthy CG; Szasz T; Webb RC
J Vasc Res; 2014; 51(6):407-17. PubMed ID: 25612650
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.
Karasu C; Ozansoy G; Bozkurt O; Erdoğan D; Omeroğlu S
Metabolism; 1997 Aug; 46(8):872-9. PubMed ID: 9258267
[TBL] [Abstract][Full Text] [Related]
18. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
[TBL] [Abstract][Full Text] [Related]
19. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.
Yao L; Chandra S; Toque HA; Bhatta A; Rojas M; Caldwell RB; Caldwell RW
Cardiovasc Res; 2013 Mar; 97(3):509-19. PubMed ID: 23250919
[TBL] [Abstract][Full Text] [Related]
20. Pravastatin normalizes ET-1-induced contraction in the aorta of type 2 diabetic OLETF rats by suppressing the KSR1/ERK complex.
Nemoto S; Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(7):H893-902. PubMed ID: 22886408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
